文献速递头颈外科

头颈癌幸存者颈部淋巴水肿相关的预后因素与结局

Prognostic Factors and Outcomes Associated With Neck Lymphedema in Head and Neck Cancer Survivors.
PubMed 文献 · Laryngoscope · 2024-03-19

本研究对203例接受放疗(±化疗)的头颈鳞癌患者进行横断面二次分析,88例(43.4%)出现治疗后淋巴水肿。多因素分析显示治疗前BMI(OR=1.07)和N分期(OR=1.96)为独立预测因素;淋巴水肿与吞咽功能障碍加重、张口度减小和疲劳增加相关。

要点

  • 203例非手术治疗头颈癌患者中88例(43.4%)出现治疗后颈部淋巴水肿。
  • 治疗前BMI(OR=1.07,95%CI 1.01-1.14)和N分期(OR=1.96,95%CI 1.06-3.66)为独立预测因素。
  • 淋巴水肿与吞咽功能障碍加重、张口度减小及疲劳增加相关。

核心结论

  • 治疗前较高BMI和较高N分期是非手术治疗头颈癌患者发生淋巴水肿的独立预测因素。
  • 发生淋巴水肿的患者报告吞咽功能障碍加重及张口受限和疲劳相关症状增加。
  • 识别淋巴水肿高风险患者有助于早期干预、减轻症状负担和优化医疗资源。

研究设计与样本

  • 横断面二次分析,纳入203例接受放疗(±化疗)的头颈鳞状细胞癌患者。
  • 排除放疗完成后<6周或>2年就诊者以及复发或转移性癌症患者。
  • 采用多因素回归模型分析淋巴水肿与预测因素及症状的关系。

主要发现

  • 203例患者中88例(43.4%)发生治疗后淋巴水肿。
  • 治疗前BMI与淋巴水肿独立相关(OR=1.07,95%CI 1.01-1.14,p=0.016)。
  • N分期与淋巴水肿独立相关(OR=1.96,95%CI 1.06-3.66,p=0.032)。
  • 淋巴水肿与吞咽功能障碍加重相关(3.48,95%CI 0.20-6.75,p=0.038)。
  • 淋巴水肿与张口度减小相关(-3.70,95%CI -7.31至-0.10,p=0.044),与疲劳增加相关(1.88,95%CI 1.05-3.38,p=0.034)。

关键数值与推荐

  • 治疗前BMI每增加1个单位,淋巴水肿风险OR=1.07(95%CI 1.01-1.14,p=0.016)。
  • N分期较高者淋巴水肿风险OR=1.96(95%CI 1.06-3.66,p=0.032)。
  • 淋巴水肿患者吞咽功能障碍评分增加3.48(95%CI 0.20-6.75,p=0.038)。
  • 淋巴水肿患者张口度减小3.70(95%CI -7.31至-0.10,p=0.044)。
  • 淋巴水肿患者疲劳评分增加1.88(95%CI 1.05-3.38,p=0.034)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The purpose of this study is to determine the predictors of neck lymphedema and to explore its association with symptoms and patient-reported outcomes (PROs) in Head and Neck Cancer (HNC) patients who underwent non-operative treatment. METHODS: This study involved a cross-sectional secondary analysis of data from patients diagnosed with head and neck squamous cell carcinoma who underwent radiation therapy (±chemotherapy). Patients with visits <6 weeks or >2 years following completion of radiation and those with recurrent or metastatic cancer were excluded. Presence of post-treatment lymphedema, demographics, clinical characteristics, health-related behaviors, and symptoms were collected. PROs were obtained using validated questionnaires that assessed depression, anxiety, swallowing dysfunction, and quality of life (QOL). Multivariable regression models were used to examine the relationship between lymphedema with predictors and symptoms. RESULTS: Of the 203 patients included, 88 (43.4%) developed post-treatment lymphedema. In multivariable analysis, pre-treatment Body Mass Index (BMI) (odds ratio [OR] = 1.07, 95% confidence interval [CI] [1.01, 1.14] p = 0.016) and N stage (OR = 1.96, 95% CI [1.06, 3.66], p = 0.032) were found to be independently associated with lymphedema. Regarding PROs, lymphedema was associated with greater swallowing dysfunction (3.48, 95% CI [0.20, 6.75], p = 0.038), decreased mouth opening (-3.70, 95% CI [-7.31, -0.10], p = 0.044), and increased fatigue (1.88, 95% CI [1.05, 3.38], p = 0.034). CONCLUSION: Higher pre-treatment BMI and greater N stage are identified as independent predictors for lymphedema development in non-operative HNC patients. Additionally, patients experiencing lymphedema reported worsening swallowing dysfunction and increased symptoms related to trismus and fatigue. Recognizing patients at elevated risk for lymphedema allows for early intervention, alleviation of symptom burden, and optimization of health care resources. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:3656-3663, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lao IJ, Berry J, Li J, et al. Prognostic Factors and Outcomes Associated With Neck Lymphedema in Head and Neck Cancer Survivors. Laryngoscope. 2024. PMID: 38501703. doi:10.1002/lary.31396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。